These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29707826)

  • 1. Pulmonary hypertension is not a risk factor for grade 3 primary graft dysfunction after lung transplantation.
    Cottini SR; Brandi G; Pagnamenta A; Weder W; Schuepbach RA; Béchir M; Huber LC; Benden C
    Clin Transplant; 2018 May; 32(5):e13251. PubMed ID: 29707826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant dyslipidaemia influences primary graft dysfunction after lung transplantation.
    Cottini SR; Ehlers UE; Pagnamenta A; Brandi G; Weder W; Schuepbach RA; Béchir M; Benden C
    Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):402-5. PubMed ID: 26718318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of right ventricular function on the development of primary graft dysfunction after lung transplantation.
    Pérez-Terán P; Roca O; Rodríguez-Palomares J; Sacanell J; Leal S; Solé J; Rochera MI; Román A; Ruiz-Rodríguez JC; Gea J; Evangelista A; Masclans JR
    J Heart Lung Transplant; 2015 Nov; 34(11):1423-9. PubMed ID: 26169669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations.
    Bittner HB; Binner C; Lehmann S; Kuntze T; Rastan A; Mohr FW
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):462-7; discussion 467. PubMed ID: 17188884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mode of intraoperative support on primary graft dysfunction after lung transplant.
    Loor G; Huddleston S; Hartwig M; Bottiger B; Daoud D; Wei Q; Zhang Q; Ius F; Warnecke G; Villavicencio MA; Tirabassi B; Machuca TN; Van Raemdonck D; Frick AE; Neyrinck A; Toyoda Y; Kashem MA; Landeweer M; Chandrashekaran S
    J Thorac Cardiovasc Surg; 2022 Nov; 164(5):1351-1361.e4. PubMed ID: 35236625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension.
    Porteous MK; Lee JC; Lederer DJ; Palmer SM; Cantu E; Shah RJ; Bellamy SL; Lama VN; Bhorade SM; Crespo MM; McDyer JF; Wille KM; Localio AR; Orens JB; Shah PD; Weinacker AB; Arcasoy S; Wilkes DS; Ware LB; Christie JD; Kawut SM; Diamond JM;
    Ann Am Thorac Soc; 2017 Oct; 14(10):1514-1522. PubMed ID: 28719755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung size mismatch and primary graft dysfunction after bilateral lung transplantation.
    Eberlein M; Reed RM; Bolukbas S; Diamond JM; Wille KM; Orens JB; Brower RG; Christie JD;
    J Heart Lung Transplant; 2015 Feb; 34(2):233-40. PubMed ID: 25447586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of anastomosis time during lung transplantation on primary graft dysfunction.
    Vandervelde CM; Vos R; Vanluyten C; Fieuws S; Verleden SE; Van Slambrouck J; De Leyn P; Coosemans W; Nafteux P; Decaluwé H; Van Veer H; Depypere L; Dauwe DF; De Troy E; Ingels CM; Neyrinck AP; Jochmans I; Vanaudenaerde BM; Godinas L; Verleden GM; Van Raemdonck DE; Ceulemans LJ
    Am J Transplant; 2022 May; 22(5):1418-1429. PubMed ID: 35029023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis.
    Fang A; Studer S; Kawut SM; Ahya VN; Lee J; Wille K; Lama V; Ware L; Orens J; Weinacker A; Palmer SM; Crespo M; Lederer DJ; Deutschman CS; Kohl BA; Bellamy S; Demissie E; Christie JD;
    Chest; 2011 Apr; 139(4):782-787. PubMed ID: 20864607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.
    Lederer DJ; Kawut SM; Wickersham N; Winterbottom C; Bhorade S; Palmer SM; Lee J; Diamond JM; Wille KM; Weinacker A; Lama VN; Crespo M; Orens JB; Sonett JR; Arcasoy SM; Ware LB; Christie JD;
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1055-61. PubMed ID: 21799077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
    Kanou T; Nakahira K; Choi AM; Yeung JC; Cypel M; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):490-499.e2. PubMed ID: 32928548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation.
    Domingo E; Grignola JC; Aguilar R; Messeguer ML; Roman A
    Respir Res; 2017 May; 18(1):85. PubMed ID: 28477618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse outcomes associated with pulmonary hypertension in chronic obstructive pulmonary disease after bilateral lung transplantation.
    Hayes D; Tumin D; Budev MM; Tobias JD; St John RC; Kukreja J
    Respir Med; 2017 Jul; 128():102-108. PubMed ID: 28476472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary Pulmonary Hypertension Among Patients Qualified for Lung Transplantation: Single-Center Study.
    Stącel T; Urlik M; Nęcki M; Antończyk R; Latos M; Wajda-Pokrontka M; Tatoj Z; Zawadzki F; Przybyłowski P; Zembala M; Ochman M
    Transplant Proc; 2020 Sep; 52(7):2101-2109. PubMed ID: 32336653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of preoperative pulmonary artery diastolic pressure on predicting primary graft dysfunction after bilateral lung transplantation for patients with idiopathic pulmonary fibrosis].
    Zhang F; Xu H; Jiang S; Li J; Lu S; Wang D; Zang Z; Pan H; Chen J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 May; 29(5):442-447. PubMed ID: 28524034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recipient Comorbidities for Prediction of Primary Graft Dysfunction, Chronic Allograft Dysfunction and Survival After Lung Transplantation.
    Ehrsam JP; Schuurmans MM; Laager M; Opitz I; Inci I
    Transpl Int; 2022; 35():10451. PubMed ID: 35845547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1-esterase-inhibitor for primary graft dysfunction in lung transplantation.
    Sommer W; Tudorache I; Kühn C; Avsar M; Salman J; Ius F; Gras C; Weber P; Welte T; Gottlieb J; Haverich A; Warnecke G
    Transplantation; 2014 Jun; 97(11):1185-91. PubMed ID: 24573112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation.
    Dotan Y; Stewart J; Gangemi A; Wang H; Aneja A; Chakraborty B; Dass C; Zhao H; Marchetti N; D'Alonzo G; Cordova FC; Criner G; Mamary AJ
    BMJ Open Respir Res; 2020 Jul; 7(1):. PubMed ID: 32661103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Intraoperative Support Strategies on Endothelial Injury and Clinical Lung Transplant Outcomes.
    Coster JN; Noda K; Ryan JP; Chan EG; Furukawa M; Luketich JD; Sanchez PG
    Semin Thorac Cardiovasc Surg; 2024 Autumn; 36(3):358-368. PubMed ID: 36716942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal Support During Bilateral Sequential Lung Transplantation in Patients With Pulmonary Hypertension: Risk Factors and Outcomes.
    Shah PR; Boisen ML; Winger DG; Marquez J; Bermudez CA; Bhama JK; Shigemura N; D'Cunha J; Subramaniam K
    J Cardiothorac Vasc Anesth; 2017 Apr; 31(2):418-425. PubMed ID: 27842947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.